Hugel Inc.

Hugel Inc.
Stock Exchange Korea Exchange
EPS
KRW16028
Market Cap
KRW1.9 T
Shares Outstanding
4.36 M
Public Float
2.29 M

Profile

Address
61-20 Sinbuk-ro
Chuncheon-si GA 24206
Korea, Republic Of
Employees -
Website http://www.hugel.co.kr
Updated 09/14/2018
Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. Its products include botulinum toxin, hyaluronic acid fillers, facial masks, concealers, and moisturizers. The company was founded on November 22, 2001 and is headquartered in Chuncheon-si, South Korea.

Financials

View All
Created with Highcharts 5.0.14Hugel Inc.Net Income. Fiscal year is January-December. All values KRW Millions.7 3077 30713 15013 15033 92933 92943 27343 27372 82772 82720132014201520162017020k40k60k80k
Created with Highcharts 5.0.14Hugel Inc.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.29 17029 17040 35040 35065 06665 066124 189124 189182 085182 08520132014201520162017050k100k150k200k

Ji-Hun Son
Chief Executive Officer & Director
Do-Hyeon Kim
Director & Head-Finance